Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy. - Vogel, Marco M. E.; Kroeze, Stephanie G. C.; Henkenberens, Christoph; Schmidt-Hegemann, Nina-Sophie; Kirste, Simon; Becker, Jessica; Burger, Irene A.; Derlin, Thorsten; Bartenstein, Peter; Mix, Michael; la Fougère, Christian; Eiber, Matthias; et al. (European Journal of Nuclear Medicine & Molecular Imaging, 2020)